The latest announcement is out from FOXO Technologies ( (FOXO) ).
On March 19, 2025, FOXO Technologies Inc. announced a non-binding agreement to acquire Vector Biosource Inc., a provider of information and biospecimen sourcing for the biotechnology, clinical research, and pharmaceutical industries. The acquisition is expected to enhance FOXO’s strategic positioning by expanding its platform and providing growth capital and corporate infrastructure to Vector, potentially increasing revenues and synergies with other FOXO subsidiaries.
More about FOXO Technologies
FOXO Technologies Inc. operates in the biotechnology industry, focusing on improving human health and lifespan through innovative technology and product solutions. The company owns and operates three subsidiaries: Rennova Community Health, Inc., which manages a critical access hospital in East Tennessee; Myrtle Recovery Centers, Inc., a behavioral health facility providing detox and residential treatment services; and Foxo Labs, Inc., which is dedicated to biotechnology advancements.
YTD Price Performance: -46.90%
Average Trading Volume: 7,495,168
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.89M
For detailed information about FOXO stock, go to TipRanks’ Stock Analysis page.